{"id":"https://openalex.org/W2946989458","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.tps5602","title":"Phase 2 trial of tisotumab vedotin in platinum-resistant ovarian cancer (innovaTV 208).","display_name":"Phase 2 trial of tisotumab vedotin in platinum-resistant ovarian cancer (innovaTV 208).","publication_year":2019,"publication_date":"2019-05-20","ids":{"openalex":"https://openalex.org/W2946989458","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.tps5602","mag":"2946989458"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2019.37.15_suppl.tps5602","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.tps5602","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2019.37.15_suppl.tps5602","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089239939","display_name":"Haider Mahdi","orcid":"https://orcid.org/0000-0002-6343-5314","observed_orcids":["https://orcid.org/0000-0002-6343-5314"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Haider Mahdi","raw_affiliation_strings":["The Cleveland Clinic, Cleveland, OH;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Cleveland Clinic, Cleveland, OH;","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053966748","display_name":"Steven Robert Schuster","orcid":"https://orcid.org/0000-0002-7766-6295","observed_orcids":["https://orcid.org/0000-0002-7766-6295"]},"institutions":[{"id":"https://openalex.org/I2799336735","display_name":"Poudre Valley Hospital","ror":"https://ror.org/038c5sp60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799336735","https://openalex.org/I4210087413"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven Robert Schuster","raw_affiliation_strings":["UC Health Poudre Valley Hospital, Fort Collins, CO;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UC Health Poudre Valley Hospital, Fort Collins, CO;","institution_ids":["https://openalex.org/I2799336735"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021359849","display_name":"David M. O\u2019Malley","orcid":"https://orcid.org/0000-0002-2828-0177","observed_orcids":["https://orcid.org/0000-0002-2828-0177"]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David M. O'Malley","raw_affiliation_strings":["The Ohio State University Comprehensive Cancer Center, Hilliard, OH;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Ohio State University Comprehensive Cancer Center, Hilliard, OH;","institution_ids":["https://openalex.org/I2799885155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085552608","display_name":"Donna M. McNamara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1324520350","display_name":"Hackensack University Medical Center","ror":"https://ror.org/008zj0x80","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1324520350"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Donna M. McNamara","raw_affiliation_strings":["Hackensack University Medical Center, Hackensack, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hackensack University Medical Center, Hackensack, NJ;","institution_ids":["https://openalex.org/I1324520350"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003944586","display_name":"Reshma A. Rangwala","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I266595603","display_name":"Genmab (United States)","ror":"https://ror.org/05258cy55","country_code":"US","type":"company","lineage":["https://openalex.org/I266595603","https://openalex.org/I4210163256"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Reshma A. Rangwala","raw_affiliation_strings":["Genmab US, Inc., Princeton, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genmab US, Inc., Princeton, NJ;","institution_ids":["https://openalex.org/I266595603"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023357912","display_name":"Shang-Ying Liang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I99319750","display_name":"Seagen (United States)","ror":"https://ror.org/01vwesc15","country_code":"US","type":"company","lineage":["https://openalex.org/I99319750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shang-Ying Liang","raw_affiliation_strings":["Seattle Genetics, Inc., Bothell, WA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seattle Genetics, Inc., Bothell, WA;","institution_ids":["https://openalex.org/I99319750"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Shweta Jain","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I99319750","display_name":"Seagen (United States)","ror":"https://ror.org/01vwesc15","country_code":"US","type":"company","lineage":["https://openalex.org/I99319750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shweta Jain","raw_affiliation_strings":["Seattle Genetics, Inc., Bothell, WA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seattle Genetics, Inc., Bothell, WA;","institution_ids":["https://openalex.org/I99319750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013681510","display_name":"Leonardo Nicacio","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I99319750","display_name":"Seagen (United States)","ror":"https://ror.org/01vwesc15","country_code":"US","type":"company","lineage":["https://openalex.org/I99319750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leonardo Nicacio","raw_affiliation_strings":["Seattle Genetics, Inc., Bothell, WA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seattle Genetics, Inc., Bothell, WA;","institution_ids":["https://openalex.org/I99319750"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108521575","display_name":"Hye Sook Chon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hye Sook Chon","raw_affiliation_strings":["H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"37","issue":"15_suppl","first_page":"TPS5602","last_page":"TPS5602"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tisotumab-vedotin","display_name":"tisotumab vedotin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/platinum-resistant-ovarian-cancer","display_name":"platinum-resistant ovarian cancer","score":0.9800000190734863},{"id":"https://openalex.org/keywords/primary-peritoneal-cancer","display_name":"primary peritoneal cancer","score":0.7789999842643738},{"id":"https://openalex.org/keywords/fallopian-tube-cancer","display_name":"fallopian tube cancer","score":0.9779999852180481},{"id":"https://openalex.org/keywords/tissue-factor","display_name":"tissue factor","score":0.8500000238418579},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.9570000171661377},{"id":"https://openalex.org/keywords/monomethyl-auristatin-e","display_name":"monomethyl auristatin E","score":0.9039999842643738},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.7990000247955322},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.7799999713897705}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9056687951087952},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6433126926422119},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.6396424174308777},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6091543436050415},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.5670302510261536},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5094619393348694},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.46880534291267395},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4290919899940491},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4290882349014282},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.33098334074020386}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2019.37.15_suppl.tps5602","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.tps5602","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2019.37.15_suppl.tps5602","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3089183402","https://openalex.org/W2977407502","https://openalex.org/W4281685079","https://openalex.org/W4283072502","https://openalex.org/W3029979615","https://openalex.org/W2326056884","https://openalex.org/W4408572345","https://openalex.org/W4392634220","https://openalex.org/W2889866656","https://openalex.org/W4400907318"],"abstract_inverted_index":{"TPS5602":[0],"Background:":[1],"Ovarian":[2],"cancer":[3],"(OC)":[4],"is":[5,45,81,92,103,147,282,324],"the":[6,118,138,165,237,256,270,275,279],"most":[7],"lethal":[8],"gynecologic":[9],"cancer,":[10],"accounting":[11],"for":[12,52,85,159,209,236,253,269,297,321],"\u2248185,000":[13],"deaths":[14],"worldwide":[15],"in":[16,37,98,135,137,171,242],"2018.":[17],"Most":[18],"patients":[19],"(pts)":[20],"initially":[21],"respond":[22],"to":[23,117,244,302,315,335],"platinum-based":[24],"chemotherapy":[25],"(chemo),":[26],"but":[27],"more":[28],"than":[29],"50%":[30],"of":[31,169,217,284],"pts":[32,61,172,182,203,246,289],"recur.":[33],"Pts":[34,211],"who":[35,247,290],"recur":[36],"\u22646":[38],"months":[39],"have":[40,205],"platinum-resistant":[41,184],"OC":[42],"(PROC),":[43],"which":[44,65],"associated":[46],"with":[47,154,173,183,212],"poor":[48],"prognosis.":[49],"Standard":[50],"therapy":[51],"PROC":[53,136,298],"includes":[54],"chemo":[55,295],"\u00b1":[56],"bevacizumab":[57],"(bev).":[58],"However,":[59],"many":[60],"receive":[62,303],"single-agent":[63],"chemo,":[64],"demonstrates":[66],"limited":[67],"response":[68,339],"and":[69,130,167,198,347],"survival":[70],"(\u224812%":[71],"ORR,":[72],"3-4":[73],"mo":[74,77],"PFS,":[75,344],"\u224812":[76],"OS).":[78],"Therefore,":[79],"there":[80],"an":[82],"urgent":[83],"need":[84],"novel":[86,94],"therapeutic":[87],"strategies.":[88],"Tissue":[89],"factor":[90],"(TF)":[91],"a":[93,104,110,131,148,155,160],"oncogenic":[95],"target":[96],"expressed":[97],"OC.":[99,210],"Tisotumab":[100],"vedotin":[101],"(TV)":[102],"first-in-class":[105],"antibody":[106,115],"drug":[107],"conjugate":[108],"comprising":[109],"TF-targeted":[111],"fully":[112],"human":[113],"monoclonal":[114],"conjugated":[116],"microtubule-disrupting":[119],"agent":[120],"monomethyl":[121],"auristatin":[122],"E.":[123],"TV":[124,170,258,304],"has":[125],"shown":[126,314],"encouraging":[127],"antitumor":[128],"activity":[129],"manageable":[132],"safety":[133,156,168,233],"profile":[134],"multicohort":[139],"phase":[140,151,158,235,287,322],"1/2":[141],"innovaTV":[142,145,176],"201":[143],"study.":[144],"208":[146,177],"multicenter,":[149],"open-label,":[150],"2":[152,323],"trial":[153,350],"run-in":[157,234],"dose-dense":[161],"regimen":[162,296],"(DDR)":[163],"evaluating":[164],"efficacy":[166],"PROC.":[174,254],"Methods:":[175],"will":[178,229,239,259,299],"enroll":[179],"\u2248142":[180],"adult":[181],"epithelial":[185],"ovarian,":[186],"primary":[187,280,319],"peritoneal,":[188],"or":[189,223,309],"fallopian":[190],"tube":[191],"cancer;":[192],"measurable":[193],"disease":[194],"by":[195,327,341],"RECIST":[196,328],"v1.1;":[197],"ECOG":[199],"score":[200],"0-1.":[201],"Eligible":[202],"must":[204],"received":[206,248,291],"bev-containing":[207],"treatment":[208,251],"platinum-refractory":[213],"disease,":[214,222],"increased":[215],"risk":[216],"bleeding,":[218],"active":[219],"ocular":[220],"surface":[221],"grade":[224],">":[225],"1":[226],"peripheral":[227],"neuropathy":[228],"be":[230,240,260,300,316],"excluded.":[231],"A":[232],"DDR":[238],"performed":[241],"up":[243],"12":[245],"\u22645":[249],"prior":[250,293],"regimens":[252],"In":[255,286],"DDR,":[257],"given":[261],"at":[262],"previously":[263],"decided":[264],"lower":[265],"doses":[266],"IV":[267,307,311],"3Q4W":[268],"same":[271],"dose":[272],"intensity":[273],"as":[274,306,310],"standard":[276],"1Q3W":[277,308],"dose;":[278],"endpoint":[281,320],"incidence":[283],"DLTs.":[285],"2,":[288],"\u22641":[292],"cytotoxic":[294],"randomized":[301],"administered":[305],"3Q4W,":[312],"if":[313],"tolerable.":[317],"The":[318],"confirmed":[325],"ORR":[326],"v1.1.":[329],"Secondary":[330],"endpoints":[331],"include":[332],"DOR,":[333],"time":[334],"response,":[336],"DCR,":[337],"CA-125":[338],"rate":[340],"GCIG":[342],"criteria,":[343],"OS,":[345],"pharmacokinetics,":[346],"safety.":[348],"Clinical":[349],"information:":[351],"NCT03657043.":[352]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1}],"updated_date":"2026-10-08T09:06:37.294493","created_date":"2019-06-07T00:00:00"}